Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel and aprotinin in off-pump coronary artery bypass grafting
2007-002652-42Phase 4Terminated
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Jun 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of clopidogrel and aprotinin in coronary arteriosclerosis and postoperative hemorrhage, sponsored by Royal Brompton and Harefield hospitals. Primary endpoint: Perioperative blood loss. Started Jun 2007; status: terminated.
02
Drugs
clopidogrelaprotinin
03
Conditions
coronary arteriosclerosispostoperative hemorrhage
Beyond the preview
Go deeper on 2007-002652-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002652-42.